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Abstract
Cancer of the head and neck is the sixth most frequent cancer worldwide and associated with significant morbidity.
The head and neck area is complex and divided into various anatomical and functional subunits. Imaging is
performed by cross-sectional modalities like computed tomography, magnetic resonance imaging, ultrasound and
positron emission tomography-computed tomography, usually with fluorine-18-deoxy-D-glucose. Therefore,
knowledge of the cross-sectional anatomy is very important. This article seeks to give an overview of the various
cross-sectional imaging modalities used in the evaluation of head and neck cancers. It briefly describes the
anatomy of the extracranial head and neck and the role of imaging as well as the imaging appearance of tumours
and their extension to lymph nodes, bone and surrounding tissue. The advantages and disadvantages as well as
basic requirements of the various modalities are described along with ways of optimizing imaging quality. A
general guideline for prescription of the various modalities is given. Pitfalls are many and varied and can be due to
anatomical variation, due to pathology which can be misinterpreted and technical due to peculiarities of the
various imaging modalities. Knowledge of these pitfalls can help to avoid misinterpretation. The important points to
be mentioned while reporting are also enumerated.
Background
Epidemiology
Cancer of the head and neck, excluding cancer of the
skin and lymphoma is the sixth most frequent cancer
worldwide with a current estimation of incidence being
about 600,000 per year and deaths resulting in about
300,000 per year [1]. The reported incidence rate in
2008 was 6.8 % [2]. There is a geographical variation in
the distribution of different head and neck cancers due
to differences in genetic susceptibility, cultural risk fac-
tors like smoking, drinking, betel nut chewing, preva-
lence of nutritional deficiencies, difference in diet,
socioeconomic status and presence of infectious agents,
particularly the human papillomavirus (HPV particularly
type 16), the Epstein Barr virus and human immunodefi-
ciency virus (HIV). Certain tumours also show a gender
difference with squamous cell cancers being more com-
mon in males and thyroid tumours more common in fe-
males [1–3]. Radiation exposure is an established risk
for development of thyroid cancer and for mucoepider-
moid carcinoma of the salivary glands [2, 4].
There have been reported associations with environ-
mental toxins like formaldehyde [5].
Patients with head and neck squamous cell cancer can
have synchronous and metachronous primary cancer of
the upper aerodigestive (AE) tract. They are also at risk
of developing lung cancer, oesophageal and gastric can-
cer usually due to combined smoking and alcohol con-
sumption. The annual incidence of second primary
cancer following successful therapy of a tumour has
been reported as 3-7 % [2].
Anatomy
The anatomy of the head and neck is very complex and
knowledge of anatomy is imperative for head and neck
radiologists in order to accurately localise the disease
process and its relationship to adjacent structures and to
make the correct diagnosis. On cross-sectional imaging,
the extracranial head and neck can be divided into vari-
ous anatomical spaces by fascial planes, each space hav-
ing different contents and different pathologies.
The suprahyoid neck is divided into the pharyngeal
mucosa space, the masticator space, the parapharyngeal
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space, the parotid space, the carotid space, the retro-
pharyngeal space and the perivertebral space including
the vertebrae (Fig. 1a).
The infrahyoid neck spaces consist of the visceral
space including the trachea, esophagus, thyroid and
parathyroid glands, the carotid space, the retropharyn-
geal space and the perivertebral space which extend
downwards from the suprahyoid neck (Fig. 1b).
The carotid, perivertebral and retropharyngeal spaces
are long vertical spaces extending from the skull base
into the chest. The retropharyngeal space is a potential
space bounded anteriorly by the visceral fascia and pos-
teriorly by the prevertebral fascia and extends from the
base of the skull to the posterior mediastinum till about
the level of the carina. The perivertebral space includes
the longus colli muscles, the paraspinal muscles, verte-
brae, vertebral artery and vein and the spinal cord.
Knowledge of these spaces and their displacement pat-
terns help in localisation of the lesions to the various
spaces and facilitates the correct diagnosis. Table 1 con-
tains a list of the various spaces with their contents and
the tumours which can arise in each space. These spaces
also act as potential pathways for spread of disease. Ma-
lignant tumours can grow across spaces and are transpa-
tial or tumours can be multispatial in different spaces
simultaneously, for example lymphoma and metastases.
Furthermore, the head and neck area is divided into sev-
eral anatomical and functional units, with each having a
different pattern of tumour spread and T staging (Fig. 2).
These include the:
(1)The nasal cavity and paranasal sinuses (PNS)
(2)The oral cavity and lips, the buccal mucosa, the
upper and lower alveolar ridges, retromolar gingiva,
floor of the mouth, hard palate and the tongue
anterior to the circumvallate papillae
(3)The nasopharynx
(4)The oropharynx consisting of the soft palate
including uvula, tonsils, base of the tongue and
pharyngeal walls
(5)The hypopharynx or laryngopharynx consisting of
the pyriform sinus, postcricoid area and posterior
hypopharyngeal wall
(6)The larynx which is divided into the supraglottic
portion (suprahyoid epiglottis with both lingual and
laryngeal surfaces, aryepiglottic folds, arytenoid
cartilages, the false vocal cords and the ventricles),
the glottis (true vocal cords and the anterior and
posterior commissures) and the subglottis which
starts below the true vocal cords to the inferior
margin of the cricoid
(7)The major and minor salivary glands
(8)The thyroid gland
Tumours
Tumours can be benign or malignant and can arise from
the skin, the mucosa, the major and minor salivary
glands, the thyroid, the lymph nodes, the mesenchymal
tissues including the bone, cartilage, fibrous tissue, fat,
muscles and nerves. They can arise locally or be part of
a systemic malignancy. 90 % of head and neck neo-
plasms consist of epithelial malignancies of the mucosal
membranes of the upper AE tract called head and neck
squamous cell cancer (HNSCC). The second group con-
sists of glandular tumours arising in the major and
minor salivary glands and in the thyroid gland. Skin can-
cer and non-melanoma skin cancer of the head and neck
are considered a separate group. Other less frequent tu-
mours include localised lymphoma, sarcomas of bone
and soft tissues, and neuroectodermal tumours like para-
ganglioma, olfactory neuroblastoma, neuroendocrine
carcinoma and malignant melanoma [2]. Very superficial
lesions of the mucosa are easily seen clinically, but may
not always be identified on cross-sectional imaging due
to their small volume.
Treatment options include surgery, chemotherapy and
radiotherapy. Treatment varies according to the type of
tumours and their site of origin. We mainly need to detect
and localise the tumour and define the extent of spread,
the final diagnosis is then made by the pathologist.
Fig. 1 Axial T2-weighted images showing the deep spaces of the suprahyoid neck at the level of the oropharynx a and the infrahyoid neck at the level
of the thyroid b which are demarcated by the deep fascia of the neck. The retropharyngeal space is a potential space
between the perivertebral space and the pharyngeal mucosa space above and the visceral space below the level of the hyoid bone
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Imaging modalities
The cross-sectional imaging modalities available include
computed tomography (CT), magnetic resonance imaging
(MRI), ultrasound (US) and positron emission tomography-
computed tomography with fluorine-18-deoxy-D-glucose
(18FDG PET-CT). Each modality has its own strengths and
weaknesses; these are enumerated below.
Ultrasound
This is easily available, entails no radiation, is portable,
cheap, has a high resolution and assessment of blood
vessels and tumour vascularity can be performed in real
time without giving contrast media. Intravascular con-
trast media (SonoVueR) can be given to evaluate en-
hancement of lesions. Ultrasound is ideal for guiding
interventions where the lesion is well visualised.
The disadvantages of ultrasound include operator de-
pendency and the fact that sound waves are not transmit-
ted through bone and air, resulting in nonvisualisation of
structures behind bones and air collections. Very large
lesions can be difficult to evaluate completely and multiple
lesions require conscientious documentation.
Computerised tomography (CT)
This is usually the first modality used because it is widely
available, relatively cheap, quick and easy to perform and
reproducible. The examination time is short with less mo-
tion artefacts than an MR scan. Thin slice, high resolution
image acquisition allows high quality multiplanar recon-
structions with superior evaluation of bony structures and
calcifications. The study can be easily extended to the rest
of the body for staging purposes. Evaluation of CT images
is also easier than evaluation of MR images.
Disadvantages of CT include radiation exposure,
poorer soft tissue contrast compared to MRI, the need
to inject iodinated contrast medium to improve contrast
with the risk of contrast induced nephropathy and arte-
facts due to dental amalgam or orthopaedic material, if
present. Contraindications to CT can be absolute or rela-
tive and include allergy to contrast media, kidney failure
Table 1 Deep spaces of the neck with contents and tumours which can arise
Space Contents Tumours
1 Pharyngeal mucosa space Mucosa with minor salivary glands
Lymphoid tissue
Pharyngobasilar fascia
Levator and constrictor muscles
Cartilaginous eustachian tube
Squamous cell carcinoma of pharynx
Minor salivary gland tumours, lymphoma
2 Parapharyngeal space Fat
Minor salivary glands
Trigeminal nerve (V3)
Lymph nodes
Internal maxillary / ascending pharyngeal artery
Lipomas, liposarcoma
Minor salivary gland tumours
Schwannomas
Soft tissue sarcoma
Metastatic lymph nodes
3 Masticator space Muscles of mastication
Mandibular ramus and body
Inferior alveolar nerve
Sarcoma of muscle or bone, metastases
Lymphomas, direct spread of carcinoma,
Minor salivary tumour,
4 Parotid space Parotid gland
Intraparotid lymph nodes
Facial nerve (VII)
External carotid artery / retromandibular vein
Salivary gland tumours like mucoepidermoid
carcinoma, adenoid cystic cancer etc.
Metastatic adenopathy
Lymphomas
Oncocytomas, schwannomas, lipomas
5 Carotid space Cranial nerves IX-XII
Sympathetic nerves
Jugular chain nodes
Carotid artery / jugular vein
Schwannomas
Neurofibromas
Paragangliomas
Metastatic adenopathy
6 Retropharyngeal space Lymph nodes
Fat
Ectopic salivary gland tissue
Metastatic lymphadenopathy, lymphomas
Salivary gland tumours
Rhabdomyosarcomas
7 Perivertebral, vertebral Vertebrae
Prevertebrale muscles
Blood vessels
Paraspinal muscles
Phrenic nerve
Primary and secondary bone tumours
Plasmacytoma
Sarcomas, chordoma
Lymphomas
Metastatic lymph nodes
8 Visceral space (infrahyoid neck) Oesophagus
Thyroid glands
Parathyroid glands
Trachea
Nerves and vessels
Squamous cell carcinomas
Minor salivary gland tumours
Sarcomas
Thyroid gland tumours
Parathyroid tumours
Metastases
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with some remaining function, hyperthyroidism, thyroid
cancer, bodyweight above 200 kg and inability to lie
down. Children are preferentially scanned with MRI or
ultrasound when feasible to avoid radiation exposure.
Magnetic resonance imaging (MRI)
This has many advantages: good soft tissue contrast,
multiplanar scanning, evaluation of blood vessels with-
out giving contrast media, no radiation exposure, no
iodine containing contrast needs to be given. Functional
imaging like diffusion-weighted imaging, perfusion and
dynamic enhancement studies can be performed.
The main disadvantages include higher costs and lon-
ger acquisition time. The investigation is more complex
with many possible sequences which can be performed
and evaluation of the images is also more demanding.
There are a multitude of potential artefacts (motion ar-
tefacts, flow artefacts, field distortion artefacts due to
metal or at air bone interfaces or with blood products)
which can mimic or obscure pathology. The face, neck
and base of the skull have multiple soft tissue, air and
bone interfaces with increased chance of susceptibility
artefacts. Additionally movement and swallowing arte-
facts can degrade image quality. Examination of larger
body areas is limited by longer duration of image acqui-
sition. Gadolinium containing contrast agents should be
given to evaluate tumours and abscesses. Contraindica-
tions to the use of gadolinium are absolute or relative
and include previous or pre-existing nephrogenic sys-
temic fibrosis (NSF), previous anaphylactic reaction to
gadolinium containing contrast agents, patients with a
glomerular filtration rate below 30 ml/min/1,73 m2, un-
stable renal impairment, hepatorenal syndrome or
chronic liver function disorders and pregnancy. The
risk-benefit of giving Gadolinium has to be discussed
with the referring physician. Since macrocyclic com-
pounds of gadolinium are known to be more stable than
linear compounds of gadolinium, they should be prefera-
bly given if absolutely necessary.
There are also absolute and relative contraindications
to performing MRI. A body weight over 200 kg pre-
cludes an MRI as the table cannot carry this weight.
Other contraindications include ferromagnetic metal
fragments near vital structures, metal implants in the
area of interest, older pacemakers, nerve stimulators,
pumps, cochlear implants and stapes prostheses, claus-
trophobia, very ill patients, patients who cannot lie down
for long periods of time due to pain or increased risks of
aspiration.
Positron emission tomography-computed tomog-
raphy with fluorine-18-Deoxy-D-Glucose (18FDG
PET-CT)
The advantages include evaluation of the whole body
including the area of interest, lymph node involve-
ment, detection and exclusion of distant metastases
and the high sensitivity of detection of glucose up-
take. One big disadvantage is that it is nonspecific as
uptake is also increased in inflammation. It is also
more expensive, time consuming, requires patient to
be fasting for 6 h, the scanning time is 20–30 min
and the total investigation time is about 2–3 h. There
is some radiation exposure which varies depending on
whether a low dose CT is done for attenuation cor-
rection or a diagnostic quality CT is performed. Inter-
pretation can be difficult in areas of complex
anatomy, physiological variants and unusual patterns
of high FDG- uptake in the head and neck.
PET image evaluation is mainly performed by qualita-
tive visual assessment. Visual assessment requires defin-
ition of a threshold for judgement of existence and
degree of radiotracer concentration. A semi-quantitative
parameter currently used for PET is the standardised up-
take value, which is defined as the tissue concentration
Fig. 2 Sagittal T2-weighted image of the extracranial head and neck showing the division of the anatomical and functional units of the upper
aerodigestive tract
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of tracer within a lesion divided by tissue density, as
measured by PET, divided by the injected dose normal-
ised to patient weight multiplied by a decay factor. In-
stead of body weight, the injected dose may also be
corrected by the lean body mass, or body surface area
(BSA). Different tumours also show different glucose up-
take and there is no standard threshold value for diagno-
sis of tumours, however it can be useful for therapy
monitoring.
Role of imaging
Clinical examination and endoscopy can visualise tu-
mours in the mucosa of the upper AE tract. However,
not all areas are well visualised and submucosal and dee-
per tumours cannot be seen.
The role of imaging lies in the detection or exclusion of
tumours, the characterisation of tumours if present and
also to delineate it’s size and extent, to see which struc-
tures are involved, whether there is spread to regional
lymph nodes, perineural or perivascular spread, bony in-
vasion or in staging examinations, to detect metastases.
Imaging is also used for obtaining tissue diagnosis by
image guided biopsies, for planning therapy (radiother-
apy, computer assisted surgery), to follow patients under
therapy if necessary, to evaluate response to treatment
allowing change in therapy when possible and after
treatment, to detect recurrences before it becomes clin-
ically evident to improve chances of successful salvage.
Primary imaging (before therapy)
CT and MRI are commonly used and provide most of the
relevant information when the study parameters are opti-
mised. Information provided by the different modalities
are usually complementary. The choice of the primary im-
aging modality depends on what the clinician wants to
know, the available technology, cost factors, reimburse-
ment policies, clinician acceptance and patient factors like
presence of contraindications to MRI (older pacemakers,
metal fragments, aneurysmal clips) or contraindications to
the use of iodinated contrast media (allergy, renal failure,
thyroid cancer). For paediatric patients, radiation exposure
is an important factor to consider and therefore MRI
should be performed in children-if available.
The ideal initial study is one which is safe and provides
all the information required for proper management.
This depends on the site of origin of the tumour and
known patterns of spread. The next study, if required
should be able to answer questions not clarified by the
first study.
Furthermore, distant metastases or concomitant tu-
mours which can be present due to common risk factors
should be excluded. This is usually done either by per-
forming a whole body CT or PET-CT. There are increas-
ing reports of PET-MRI, but the availability is limited.
Once the presence of a tumour is established, one has
to correctly localise the tumour and identify its extent.
Appearance of tumour and tumour extension
Tumours appear as asymmetrical thickening of the mu-
cosa (Fig. 3a) or a mass of soft tissue density on CT which
enhances according to its vascularity (Fig. 4a). Larger tu-
mours can show areas of necrosis. On MRI, (Fig. 5a-c) the
tumour is usually hyperintense to muscle on T2-
weighting and hypointense or isointense to muscle on T1-
weighting. The precontrast T1-weighted images are par-
ticularly useful in differentiating tumour from surround-
ing fat, detecting neurovascular bundle encasement and
bone marrow involvement. MRI can overestimate tumour
if inflammatory changes and bleeding is present. The use
of diffusion-weighted magnetic resonance imaging (DW-
MRI) can help to better detect and demonstrate tumour
since most squamous cell cancers are relatively hypercel-
lular and can show diffusion impediment. This is espe-
cially true and useful in patients who are imaged after
surgery, where there is surgical change in the anatomy
and edema and inflammation due to therapy.
Fig. 3 Patient with cancer of the right pyriform sinus. Contrast–enhanced CT scan a showing asymmetrical thickening of the pyriform sinus
(arrow) on the right. CT scan at a lower level b showing slight thickening of the posterolateral hypopharyngeal wall (arrowhead) and an adjacent
normal sized lymph node with central necrosis (arrow) indicating metastasis
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On PET-CT, the morphological changes due to the
tumour are seen as in CT with increased uptake of glu-
cose in those tumours which are FDG avid (Figs. 4c, 5f ),
other processes resulting in glucose uptake like inflam-
mation or biopsy will however also show increased up-
take and should be excluded when possible.
Bony erosion appears as an interruption of the hypoin-
tense cortical rim on MR (Fig. 5a-c) or the peripheral,
cortical hyperattenuating rim on CT (Fig. 5d,e). Detec-
tion of subtle erosions require thin section CT with
bone algorithm reconstruction in multiple planes. Scler-
osis can be a sign of tumour infiltration or reactive oste-
itis. Medullary involvement is better detected with MRI.
The replacement of normal hyperintense fat signal in
the bone marrow on native T1-weighting with enhancing
tissue indicate marrow involvement. Unfortunately,
these changes can also be seen in peritumoral edema, in-
flammation, coexisting periodontal diseases, osteomye-
litis, radiation fibrosis and osteoradionecrosis.
Perineural spread on CT is diagnosed when there is
enlargement or destruction of the respective nerve
foramina with replacement of normal fat signal in the
soft tissues (Fig. 6a,b). On MRI, the nerve may be
thickened and/or show increased enhancement (Fig. 6a-f).
Perineural spread can be antegrade or retrograde and
skip lesions can occur. This finding can also be seen
Fig. 5 Patient with carcinoma ex-pleomorphic adenoma of the submandibular gland on the left with invasion of the mandible. In the T2-weighted MR
image a the lesion is heterogenously hyperintense to muscle and there is loss of the cortical hypointense line indicating bone invasion (arrow). In the
T1-weighted image b the lesion is hypointense to the muscle and there is replacement of the normal high signal marrow fat by the tumour. The
T1-weighted image c after injection of gadolinium without fat saturation shows some enhancement of the lesion. Contrast enhanced CT scan at the
same level d shows the heterogenously enhancing mass which extends into the mandible. The cortical bone erosion (arrow) is seen better in the bone
window setting e. The PET-CT scan f at the same level showing the increased glucose uptake by the tumour with extension into the mandible
Fig. 4 Patient with an undifferentiated cancer of the right submandibular gland. Contrast–enhanced CT scan a showing the solid, heterogeneously
enhancing mass on the right side (star). CT scan at a slightly lower level b shows the solid metastatic lymph node (arrow). PET-CT image c showing
the intense uptake of FDG glucose by the tumour (star) and the lymph node metastasis (arrow), both seen at the same level due to difference in the
degree of neck flexion
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in inflammatory changes or due to edema of the
nerves. Secondary signs of denervation such as atro-
phy of the muscles innervated by the involved nerve,
or abnormal enhancement of the involved muscles or
clinical signs of inflammation can be helpful in this
respect.
PET-CT signs of nerve involvement include linear
thickening or linear increased/decreased FDG activity
along the expected course of the cranial nerve. Ab-
normal activity can be seen in the muscles supplied
by the nerve or increased FDG activity in the syner-
gistic/antagnostic muscles which overcompensate to
maintain function where possible. Other signs like
atrophy and foramen changes are seen on the CT
images [6].
Metastases to adjacent Iymph nodes is an important
prognostic factor. We use an image based classifica-
tion of cervical Iymph nodes described by Som et al.
[7], where lymph nodes are divided into seven sta-
tions in the neck according to their position. The ret-
ropharyngeal, occipital, facial, parotid and mastoid
lymph nodes are not included in this classification
and when involved are named according to their ana-
tomical site. Most metastatic nodes are enlarged, a
transversal short axis diameter of more than 1.5 cm
for Level II nodes, and more than 1 cm for all other
nodes in the neck are considered pathological (Fig. 4b).
However, normal sized nodes can have focal areas of ne-
crosis indicating metastases (Fig. 3b). This should be dif-
ferentiated from the fatty hilus by carefully looking at the
native scans and measuring the Hounsfield units, necrosis
also tends to be central while the hilus is eccentric [8].
Other features include increased enhancement, irregular-
ity in shape, heterogeneous enhancement and stranding or
obvious infiltration of the adjacent soft tissue which
imply extracapsular spread. Extracapsular spread is an
important finding to be mentioned in the report since
it is a marker of increased locoregional failure if only
surgery is performed and chemoradiation should also
be given.
Ultrasound can evaluate the morphology of lymph
nodes and Doppler sonography can be used to assess the
vascular pattern. Monitoring the lymph node size is also
useful in the assessment of treatment response. Enlarge-
ment of lymph nodes indicates pathology but since re-
active lymph nodes also enlarge, it is nonspecific. A
round shape with a short to long axes ratio greater than
0.5 is a useful pointer, except for submandibular and
parotid nodes which can normally be round. Eccentric
cortical hypertrophy can indicate focal tumor infiltra-
tion. The lymph node border may be smooth or irregu-
lar, irregular borders in confirmed metastases indicate
extracapsular spread. Loss of the echogenic hilus, necro-
sis (Fig. 7a) and fine calcification can all be seen in me-
tastases. Normal lymph nodes have hilar vascularity and
the presence of peripheral vascularity in lymph nodes is
a useful indicator of malignancy [9] (Fig. 7b). On PET-
CT metastatic lymph nodes show increased uptake
(Fig. 4c).
Tumour staging
Tumours are classified into stages which determine
the appropriate treatment and prognosis. The union
for international cancer control (UICC) has published
Fig. 6 Patient with adenoid cystic carcinoma and perineural extension along the inferior orbital nerve, the pteryopalatine fossa and the maxillary nerve
on the left side. Contrast enhanced CT images a, b showing the asymmetric thickened enhancing nerve (arrows) on the left. The curved arrow a shows
the normal fat density of the pterygopalatine fossa on the right side. Axial T1-weighted images d, e showing the thickened enhancing nerve (arrows)
on the left. Coronal T1-weighted images with fat saturation after injection of gadolinium c showing asymmetrical nerve enhancement (arrow) in the
cavernous sinus and f the thickened infraorbital nerve on the left (arrow)
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a staging system UICC TNM classification that is inter-
nationally accepted. It is based on the primary tumour site
characteristics like size and spread (T), involvement of
Iymph nodes (N) and the presence or absence of metasta-
ses (M). The use of this standard staging helps in treat-
ment planning, in follow up and allows exchange of
information between treatment centres. The anatomically
based TNM classification considers the local, regional and
distant extension of tumours. Due to the numerous sub-
sites in the head and neck, each with different T staging,
readers are referred to the UICC TNM classification of
malignant tumours [10].
N staging of lymph nodes is based on the site, number
and laterality of the lymph nodes relative to the primary
tumour site. It does not take into account the presence
of extracapsular spread of tumours or involvement of
retropharyngeal lymph nodes.
N staging for most tumours (except the nasopharynx
and thyroid)
Nx means that the regional lymph nodes cannot be
assessed
N0 no node involvement
N1 single ipsilateral lymph node 3 cm or less in
greatest diameter
N2a single ipsilateral lymph node between 3 and 6 cm
N2b multiple ipsilateral lymph nodes less than 6 cm
N2c contralateral or bilateral lymph nodes less
than 6 cm
N3 any lymph node larger than 6 cm.
N staging of nasopharyngeal tumours (midline nodes
are considered ipsilateral).
N0 no node involvement
N1 ipsilateral single lymph node above the
supraclavicular fossa, and/or unilateral or bilateral
retropharyngeal lymph node(s), 3 cm or less in greatest
dimension
N2a ipsilateral single lymph node between 3 to 6 cm
N2b multiple ipsilateral lymph nodes less than 6 cm
N2c contralateral or bilateral lymph node(s) 6 cm in
greatest diameter above the supraclavicular fossa
N3a lymph node or nodes larger than 6 cm, unilateral
or bilateral
N3b extension to the supraclavicular fossa
N staging for thyroid cancer
N1a level VI (pretracheal, paratracheal, prelaryngeal
/Delphian lymph nodes)
N1b unilateral, bilateral or contralateral cervical (level
I-V), retropharyngeal or superior mediastinal (level VII)
nodes.
The presence of metastases is another important prog-
nostic factor. M0 means there is no distant metastasis
and M1 indicates spread to distant organs beyond the
regional nodes.
Therapy depends on the tumour type and staging and
consists of surgery and/or chemotherapy and/or radio-
therapy. Therefore, the correct diagnosis and adequate
assessment of tumour extent is essential for proper ther-
apy of the tumours.
Imaging appearance after therapy
Imaging appearance after therapy depends on the type of
treatment received and this should be known before
evaluation of images. The expected changes after radio-
therapy include edema and inflammation with thickening,
swelling and induration of all the structures in the radi-
ation field, maximal changes are seen during the first few
months after the end of radiotherapy. These changes de-
crease with time and can be followed by atrophy and
shrinkage as in postradiation sialadenitis. Calcification
may also occur especially in lymph nodes, dystrophic cal-
cification after therapy is a potential cause of false positive
FDG PET. The changes after surgery depend on the surgi-
cal procedure which has been performed. Surgery may be
extensive with removal of significant tissue which requires
reconstruction with pedicled or free soft tissue flaps, grafts
and prosthesis. Neck dissection performed to remove
lymph nodes can be selective or radical. Accordingly there
can be significant changes in the anatomy and it can be
difficult to detect tumour in this background of altered
anatomy. Tumour recurrences appear as a soft tissue mass
Fig. 7 Lymph node metastasis a in a patient with known multifocal papillary carcinoma of the thyroid showing a small area of necrosis (arrow).
Color doppler image showing pathological peripheral vascularity b
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at the primary site on CT or MRI and after major surgery
with reconstruction, recurrence is usually seen at the edge
of the resection or the soft tissue flaps. It can be very diffi-
cult to distinguish between tumour recurrence and post-
therapeutic changes in the early stages [11]. A baseline
scan performed about 3–6 months after the end of ther-
apy can be very helpful in this respect. PET-CT has a high
negative predictive value but false positive results occur
due to the inflammatory post therapeutic changes. DW-
MRI is useful in detecting tumour in the background of
posttherapeutic inflammation [12, 13] (Fig. 8a-e).
Patients with complications after treatment may
present for imaging. Early surgical complications like fis-
tula formation can be diagnosed on fluoroscopy or on
CT after giving oral contrast media. Late complications
of radiotherapy like osteonecrosis and soft tissue necro-
sis can be seen well on both CT and MRI scans although
it can sometimes be difficult to differentiate from
tumour recurrences or infections. Radionecrosis occurs
after radiotherapy, the presence of air, sclerosis and frag-
mentation of the bone points to radionecrosis.
Prescribing
The modality prescribed depends primarily on availability.
In developed countries most modalities are available and
physician’s preference, experience, expertise, the area of
interest and the information required determines what is
prescribed. As a general guide, MRI is best for evaluation of
the oral cavity and oropharynx and for evaluation of peri-
neural tumour spread. For evaluation of the PNS, nasal cav-
ity and larynx, where soft tissue and bony details are
important, both CT and MRI are commonly used and pro-
vide complementary information. The thyroid gland is well
evaluated by ultrasound, MRI or CT, the use of iodinated
contrast media is contraindicated in cases of suspected thy-
roid cancer due to therapeutic implications. The salivary
glands can be evaluated by all cross-sectional modalities.
For evaluation of the lymph node status, all modalities can
be used. MRI is preferred for evaluation of perineural
spread.
Ultrasound is used widely for evaluation of the thy-
roid gland, neck lymph nodes and salivary glands and
in soft tissue mass evaluation and in the paediatric
population. Ultrasound guided fine needle aspiration
cytology or biopsies can be highly accurate for neck
node staging but is highly operator dependent. Also
not all areas of the neck can be adequately visualised
by ultrasound (e.g., deep lobe of the parotid, retro-
pharangeal lymph nodes) and a CT or MRI may be
required for completion of staging.
PET-CT is useful for detection of the primary tumour,
known or unknown, nodal metastases, second tumours
or distant metastases. It has a role in restaging and long
term surveillance to detect recurrence.
Fig. 8 Axial T1-weighted MR image before contrast a T1-weighted MR image after injection of gadolinium without fat saturation b and with fat satur-
ation c in a patient with diffuse thickening of the neopharynx (radial free flap reconstruction) after total laryngectomy for larynx cancer. DW-MRI shows
hyperintense signal (arrow) in the b800 image d with corresponding low signal in the ADC map e indicating tumour recurrence. The PET-CT image f
showed intense uptake of glucose (see also Fig. 10) over a long segment due to which it was interpreted as inflammation
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In our institute, patients with clinically known tu-
mours undergo a CT scan of the neck as the primary in-
vestigation. A complementary MRI is done when
possible for better tumour delineation in patients with
tumours of the oropharynx, oral cavity, nasopharynx,
PNS and for exclusion of perineural tumour spread.
Conventional CT of the thorax and abdomen is done for
staging of early tumours T1-2 N0. PET-CT is performed
for advanced tumours T3-4 where there is increased
risk of metastases, in all patients with lymph node
metastases and for cancer of unknown primary (CUP).
Most patients also undergo panendoscopy and all pa-
tients are biopsied. Ultrasound is usually reserved for
evaluation of the thyroid glands and for guiding biop-
sies in adults. Children presenting with a swelling are
preferentially evaluated first with ultrasound and then
as required, with MRI, in order to avoid radiation
exposure.
After completion of therapy, patients are assessed clin-
ically and radiologically to detect tumour persistence /
recurrence or metastases. The radiological follow up
after therapy is individualised and depends on tumour
type and tumour stage, but the general scheme applied
in our institute is a CT or MRI scan 3–4 months after
completion of therapy, which is repeated after about
1 year and 2 years. Patients with stage III and IV cancers
undergo restaging with PET-CT at 4–5 months after end
of therapy.
Image display
We use a PACS system Sectra Workstation IDS7 Ver-
sion 17.1.10. Ideally two 21 inch or one 30 inch standard
radiology monitor for image display with additional
monitors for reporting should be available. It should be
possible to view multiple images / series simultaneously.
The different sequences can be tagged to move together
thus improving efficiency and accuracy. This is especially
important for the DW-MR images where the spatial
resolution may be suboptimal. The use of the localiser
function of the PACS system allows rapid localisation of
findings in different planes. Different modalities can be
viewed simultaneuously. There should be a capability for
multiplanar reconstructions so that individualised recon-
structions can be made as required. Multiple image
viewing is especially important for comparisons of scans
during follow up (Fig. 9).
Fig. 9 PACS system Sectra Workstation IDS7 Version 17.1.10 image display. Many images can be evaluated simultaneously. The localiser function
helps to quickly localise findings in different planes and sequences
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For PET-CT images, the three dimensional volume
data is depicted in the coronal, sagittal and axial planes
with maximum intensity projections (MIP). The NM Fu-
sion software in the PACS allows fusion of the PET and
CT images and enables the three dimensional image dis-
play. There are different preset window settings and
SUV settings which can be selected (Fig. 10).
Basic requirements and image optimisation
Ultrasound
The lesion should be accessible to ultrasound without
any intervening bone or air.
Proper patient positioning with good access to the
structure to be evaluated is important. One should use
adequate gel and the correct frequency of the trans-
ducer. The higher the frequency of the transducer the
better the resolution but the penetration into the deeper
tissues is restricted and for scanning deeper tissues, the
frequency has to be reduced. We use multifrequency
transducers where the frequency is adjusted during the
scanning. It is important to know the limitations of
ultrasound and to advise either a CT or MRI when
required.
CT
State of the art CT requires multidetector CT. Volumet-
ric data are acquired rapidly, reducing volume averaging
artefacts and motion artefacts and allowing high quality
retrospective reformations. One disadvantage is the
higher radiation dose. Since CT has poor soft tissue con-
trast, intravenous iodine containing contrast agents have
to be injected. Delay between injection and scanning is
essential to allow time for the contrast to reach the area
of interest.
Proper positioning of patient supine with neck in
slight extension is important. The head should be posi-
tioned as symmetrically as possible, the patient should
be as comfortable as possible to avoid movement. Dental
amalgam can seriously degrade image quality and in
Fig. 10 PACS system Sectra Workstation IDS7 Version 17.1.10 with NM Fusion image display allowing demonstration of the volumetric PET-CT
data in all three planes and as MIP. The various preset window and SUV settings are shown in the bottom half. The PET images shows the long
segment of avid enhancement of the neopharynx in a patient with tumour recurrence (same patient as in Fig. 8) and a lymph node metastasis
on the right
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patients with tumours of the oral cavity, scanning can
be done with a tilted CT gantry or with an open
mouth. The puffed air technique which entails puffing
the cheeks out with air during scanning improves de-
lineation of oral mucosal lesions and allows identifica-
tion of site of origin of tumours. Using a modified
Valsalva maneuver, which consists of expiration against
the resistance of pursed lips or a pursed nose and holding
the breath for at least 10 s during scanning, dilatation of
the hypopharynx and its visualisation can be im-
proved. E phonation, which is performed by having
the patient say ‘e’ uniformly for at least 10 s during
scanning, also results in better depiction of the true
and false vocal cords and the laryngeal ventricles with
better localisation of site of origin of tumours.
Scanning factors can be optimised. The field of view
(FOV) should be as small as possible to optimise spatial
resolution. Image reconstructions are done using soft
tissue windows and bone windows. Lung windows
should be used to evaluate the apical lungs which are
also included in the lower neck scans to exclude metas-
tases. Volumetric scanning allows reconstruction of the
images in the correct plane, for example for larynx can-
cers along the plane of the vocal cord. Three dimen-
sional reformatting is usually used for evaluation of
bony structures. 3D volume rendering and virtual endos-
copy can also be performed.
From skull base to the oral cavity, image plane should
be parallel to the hard palate, from the oral cavity to the
thoracic inlet, image plane should be parallel to the
vocal cords which is practically parallel to the interverte-
bral disc space at C 4–5 and C 5–6 level.
MRI
A 1.5 or 3 Tesla MRI scanner is required. For lesions
near the skull base, a head coil is used and for lesions
lower in the neck, a neck coil can be used. The use
of a single receiver prevents evaluation of the Iymph
nodes status. The combination of a head and a neck
coil permits evaluation of the whole head and neck
area. Disadvantage of combination of coils is the
change in the recipient field characteristics at the
crossover between two coils. Meticulous shimming,
coil and patient positioning as well as the use of se-
quences with short echo trains can help overcome
this drawback [14].
The patient should be supine, the head and neck
should be aligned and symmetrically positioned. The pa-
tient should be positioned comfortably with slight head
fixation to reduce motion artefacts. The patient should
not cough during image acquisition. Patient should be
encouraged not to speak or swallow during image acqui-
sition even though it may not always be feasible. Sed-
ation of children can reduce movement.
Sequences: The standard sequences used in our insti-
tute include, a coronal inversion recovery sequence, axial
T1-weighted and T2-weighted images over the area of
interest, DW-MRI with three b values (50, 300, 800),
post contrast T1-weighted axial images and a volumetric
interpolated brain examination (VIBE) with fat satur-
ation over the whole neck. For evaluation of the larynx
and hypopharynx, 3 mm slice thickness is mandatory.
Otherwise 3–4 mm axial slice thickness is used. The 3D
VIBE is very good for evaluation of perineural spread. In
the presence of metal, fat saturation should not be per-
formed. Perfusion and dynamic scanning are not per-
formed routinely.
Technical parameters can be optimised. The use of faster
pulse sequences and parallel imaging if coils permit, echo
train length for diffusion can shorten the scan time, thus
improving image quality. CT is however much quicker and
to be preferred in very sick and restless patients.
Injecting MR contrast is important as it increases the
contrast between tumour and surrounding lesions improv-
ing tumour detection, necrosis is also seen better after con-
trast administration. Bone involvement detection requires
fat saturation after contrast as the signal intensity after
contrast becomes similar to the fat in the bone marrow.
DW-MRI should be performed routinely. Factors for
optimisation of diffusion-weighted images include mini-
misation of echo train length for SE echoplanar se-
quences, the use of shim blocks, zoom echo-planar
imaging, use of antisusceptibility cushion and parallel
imaging [15].
PET-CT
For evaluation of the head and neck, it is necessary to
perform dedicated high resolution head and neck CT
(HR HN PET-CT) with smaller FOV, longer acquisition
time per slice position and thinner slice thickness. This
is performed ideally with the arms lying parallel to the
body and includes giving intravenous contrast. Ideally
smaller pixels should be used, reducing partial volume
effect which underestimates FDG activity in all lesions
smaller than twice the spatial resolution. The use of the
whole body PET-CT for evaluation of head and neck
cancer is not adequate for smaller tumours.
Adequate patient preparation: patient fasting at least 6 h
prior to investigation, adequate hydration, patient instructed
not to chew or speak during the FDG uptake phase. Patient
should be kept adequately warm for 30–60 min prior
to scanning to avoid shivering and increased uptake
by the muscles. All metal that can cause artefacts are
removed. Proper patient positioning is important.
PET-CT in diabetics can be problematic due to elevated
glucose levels with competitive inhibition of FDG in dif-
ferent tissues. Intravenous insulin before FDG injection
can reduce glycaemia but it increases FDG uptake in
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muscles and fat. Monitoring serial blood sugar levels
(BSL) after giving insulin and only giving FDG when the
BSL is starting to rise or plateauing, minimises the muscu-
lar uptake due to insulin. Another option is to reschedule
the investigation if BSL are more than 120 mg/dl.
Pitfalls
Pitfalls can be due to variations in the anatomy, path-
ology which can be misinterpreted, technical factors/
changes obscuring or mimicking disease. Incidental find-
ings may be insignificant or significant and can alter pa-
tient management.
Pitfalls due to normal anatomy
Hypertrophy of the lingual tonsils can look like tumour.
The arch of the thoracic duct in the left lower neck,
Iying between the carotid and subclavian artery can
mimic a lymph node on axial images. It is a tubular
structure ending in a vein and can be identified by fol-
lowing it.
The accessory levator claviculae muscle, normal in
lower mammals, is infrequently found in humans. It
arises from the transverse process of the upper vertebrae
and inserts on the lateral half of the clavicle. It can
mimic nodes on axial scans.
The thyroid cartilage has a very variable pattern of os-
sification and areas of non-ossification can be misinter-
preted as invasion of the cartilage.
Pitfalls due to pathology
Recurrent laryngeal nerve palsy leads to asymmetry of
the vocal cords which can be misinterpreted as a
tumour.
Hypoglossal nerve palsy leads to fatty degeneration
and loss of tone of the involved half of the tongue. There
is dorsal shift of the tongue base due to gravity in the su-
pine position leading to the appearance of a pseudotu-
mour in the oropharynx (Fig. 11).
Inflammation of the nerves like neuritis is difficult
to differentiate from perineural tumour spread, clin-
ical correlation and serial scanning is required to re-
solve this.
It can be difficult to differentiate between lateral neck
cysts and cystic Iymph node metastases from papillary
cell cancer of the thyroid. It is also difficult to differenti-
ate between suppurative inflammatory and necrotic
metastatic Iymph nodes. The margins of the nodes can
be irregular and ill-defined indicating the presence of in-
flammation and clinical signs of inflammation are usu-
ally present. In those cases where the clinical features
are equivocal, DW-MRI might help but aspiration cy-
tology is usually required.
Tumor recurrence and therapeutic changes can also
be difficult to differentiate, DW-MRI imaging and serial
scanning can help, followed by biopsy when indicated.
Bony changes due to tumour infiltration / inflammation
/ radionecrosis can be difficult to differentiate, here the
clinical setting is important and DW-MRI might also help.
Technical pitfalls with CT and MRI
Inadequate scan volume where the tumour may not be
adequately included, inadequate contrast enhancement
which might allow misinterpretation of blood vessels as
Iymph nodes or too much contrast with beam hardening
artefacts obscuring the tumour. Movement artefacts can
obscure tumour. Pulsation artefacts and aliasing artefacts
can mimic tumours. T2 shine through effect in DW-
MRI can be mistaken for diffusion impediment if the
ADC maps are not looked at.
Technical pitfalls with PET-CT
There is physiological uptake by the brain, lymphoid tis-
sue, salivary glands, muscles and brown adipose fat when
present and this should not be misinterpreted as
tumour. False positive readings can occur after trauma,
biopsy, chemotherapy, inflammation. Increased uptake is
also seen in thyroid nodules with high glucose
Fig. 11 Patient with hypoglossal nerve palsy on the left. The T2-weighted MR image a the T1-weighted MR image b and the T1-weighted MRI
image with fat saturation after injection of gadolinium c shows the fatty changes of the left side of the tongue and a dorsal bulge due to loss
of muscle tone. This should not be interpreted as a tumour on the left side
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metabolism, Warthin tumour of the parotid gland and
unilateral cranial nerve palsy. Unilateral cranial nerve
palsy results in compensatory hypertrophy of the mus-
cles on the contralateral side leading to asymmetrical in-
creased uptake of glucose on the normal side. Patients
who talk or chew after FDG injection show physiological
uptake in the tongue, pterygoid muscles and vocal cords.
False negative readings can occur if the patient is not
fasting (inadequate preparation), diabetes with high
blood sugar level or in the vicinity of structures with
high glucose metabolism, due to obscuration by dental
hardware, inadequate PET scanner resolution. Well dif-
ferentiated, slow growing tumours or tumours with cen-
tral necrosis may not show any uptake. Very small
lesions with partial volume effect can be missed and in
the presence of increased background noise due to vol-
ume overload or kidney failure, lesions can be missed.
Artefacts due to dental hardware and metallic implants
propagate to the PET images through CT-based attenu-
ation correction factors [16].
Incidental findings
These can be relevant or irrelevant. Relevant findings
should be mentioned.
Retropharyngeal carotid artery when present should be
mentioned to avoid inadvertent biopsy. Presence or ab-
sence of bony septae around the skull base in cases of
computer assisted surgery in the nasal and paranasal si-
nuses is very important and should be mentioned.
Laryngoceles are benign but can be due to obstruction
at the ventricle due to stenosis or tumour and tumour
has to be excluded.
Other incidental findings like detection of other tu-
mours or findings of systemic or local illnesses, vascular
anomalies or vessel stenosis which can influence the
ability of the patient to undergo surgery or radio/chemo-
therapy can change patient management and should be
communicated to the clinician.
Irrelevant incidental findings like atheromas can be
mentioned in the findings section of the report but not
in the conclusion.
Quality control
This is important especially in referral centers where the
patients are referred with completed imaging scans. The
quality of the investigations vary greatly between differ-
ent institutions and if inadequate, they should be re-
peated. One should check whether the area of interest
and the tumour has been completely included in the
scan. The presence of artefacts, due to motion, metal or
contrast media can seriously degrade image quality. For
MRI check which sequences have been performed,
whether the fat saturation is homogenous. For PET-CT
look for undesired nucleotide deposition in the muscles,
resolution and misregistration between the CT and the
PET scan.
Reporting
It is important to identify the information that the
clinician requires and this should be addressed in the
conclusion. A mention of the technical parameters
like the different phases of contrast enhancement in
CT scans and the different MR sequences performed
should be made as well as a description of the body
part that has been scanned. Furthermore, the name
and the dose of the administered contrast medium
has to be noted. We do not use report templates or
include key images in our reports. Most oncologist
and ENT surgeons appreciate a summary statement
stating that the findings are compatible with a certain
TNM stage and it should be mentioned when pos-
sible. The TNM staging of larynx cancers includes
vocal cord fixation, a clinical parameter for staging
and the final staging is done in the interdisciplinary
tumour boards where the images and the patients are
clinically evaluated at the same time. The report
should include a detailed description of the tumour,
its size, location, extension over the midline to the
other side, the extent of local spread to bone, adja-
cent soft tissues, involvement of the blood vessels,
whether the vessels are surrounded, invaded or only
in contact. The involvement of Iymph nodes, whether
unilateral or bilateral, the number of involved nodes,
the location or level of the involved lymph nodes
according to Som [7] and presence of extracapsular
spread should be mentioned. Perineural spread, me-
tastases to bone, brain or presence of other tumours
are important. Invasion of adjacent muscles, the
prevertebral muscles and for tumours of the tongue,
involvement of extrinsic muscles increases the T
staging.
Adequacy of the investigation and whether comple-
mentary imaging is required should be mentioned in the
initial scan.
Important points to be included in the early
posttherapeutic scan are the presence or absence of re-
sidual tumour, size if present and the degree of confi-
dence for the diagnosis. In follow up scans, the presence
or absence of recurrence or complications of treatment
like osteoradionecrosis, ulcer, soft tissue necrosis and
XII nerve palsy should be mentioned. DW-MRI se-
quences can help in differentiation between tumour and
posttreatment changes. If the findings are equivocal,
then depending on the clinical situation, patients should
undergo a follow up examination or a biopsy.
Similarly for PET-CT, one should mention whether
the investigation is of adequate quality.
Tshering Vogel and Thoeny Cancer Imaging  (2016) 16:20 Page 14 of 15
Describe the location, extent and intensity of the
pathological FDG accumulation. Describe all findings in
the accompanying CT even if there is no accompanying
increased glucose uptake. Mention confounding factors
like inflammatory changes, muscle activity or high glu-
cose levels at the time of the investigation. Address the
clinical question asked. Compare with old investigations
when available. A definite diagnosis should be made if
possible, if findings are equivocal then the probability of
a diagnosis should be stated.
In cases of conflicting findings between CT, MRI and
PET-CT concerning lymph node metastases or bone and
cartilage invasion, the positive findings should be used
for staging as false negatives can occur. For lymph
nodes, the known pattern of spread can additionally be
used to determine the probability of metastatic involve-
ment. False positive results can also occur regarding
bone and cartilage involvement and discussion with the
clinicians is very important. Communication of indeter-
minate findings is especially important before surgery so
that the surgeon can plan for all eventualities preopera-
tively. All cases of head and neck cancers are always dis-
cussed in the interdisciplinary tumour conferences with
the surgeons, the oncologists and the radiation thera-
pists and treatment options are tailored to individual pa-
tients and also depend on the patient’s age, health status
and personal wishes.
Summary
The head and neck area is complex and knowledge of
anatomy is essential.
The different cross-sectional images have their
strengths and weaknesses.
The diagnosis is only as good as the images available.
Is the study adequate? If not repeat.
Is there a mass? Is it discrete, localised or generalised?
Is it confined to an anatomical space? Proper localisation
of the lesion helps in reaching the correct diagnosis. Is it
multi-spatial or trans-spatial? What are the normal con-
tents of the involved space? What are the imaging ap-
pearances and enhancement characteristics? Cystic or
solid? Inflammatory or infection? Malignant?
The next step? Further imaging? Which imaging mo-
dality ? Biopsy.
There are many pitfalls and one should be aware of
them.
Incidental findings although seemingly irrelevant can
be a clue to an underlying tumour.
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